New Elite Feature: Compare relative returns, fundamentals, and sector rankings head-to-head.

Aura Biosciences, Inc.

Contributing Author

Recent Articles by Aura Biosciences, Inc.

Jun-01	Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma AURA GlobeNewswire
May-19	Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) AURA GlobeNewswire
May-12	Aura Biosciences to Participate in Upcoming Investor Conferences AURA GlobeNewswire
May-11	Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights AURA GlobeNewswire
May-05	Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares AURA -6.85% AURA +6.59% GlobeNewswire
May-04	Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants AURA +19.12% GlobeNewswire
May-04	Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants AURA +19.12% GlobeNewswire
May-04	Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion AURA +19.12% GlobeNewswire
Mar-30	Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights AURA GlobeNewswire
Feb-25	Aura Biosciences to Participate in Upcoming Investor Conferences AURA +5.99% GlobeNewswire
Nov-24	Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference AURA +11.09% AURA GlobeNewswire
Nov-13	Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights AURA GlobeNewswire
Sep-03	Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference AURA GlobeNewswire
Aug-13	Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights AURA GlobeNewswire
May-15	Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants AURA +5.71% GlobeNewswire
May-15	Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants AURA +5.71% GlobeNewswire
May-15	Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights AURA +5.71% GlobeNewswire
May-01	Aura Biosciences to Participate in Upcoming Investor Conferences AURA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)